Infectious Disease
Congenital Cmv
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
Congenital Cmv is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
2
clinical trials
Terminated1 · 50%
Completed1 · 50%
Clinical Trials
Trial Activity
Asymptomatic Congenital CMV Treatment
Terminated·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT03301415·7 enrolled
Valganciclovir in Congenital CMV Infants
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1/2·NCT00031434·24 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)